APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-thrombotic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-thrombotic Drugs Industry Growth and Trends Forecast to 2032

27 December 2025129 pages

Choose your research edition.

Industry ResearchAnti-thrombotic Drugs Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-thrombotic Drugs Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Anti-thrombotic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-thrombotic Drugs Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-thrombotic Drugs Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Anti-thrombotic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-thrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-thrombotic Drugs include Yantai Dongcheng North Pharmaceutical Co., Ltd., Tianjin Biochemical Pharmaceutical Co., Ltd., Tianjin Hongri Pharmaceutical Co., Ltd., Sichuan Changzheng Pharmaceutical Co., Ltd., Shijiazhuang Heping Pharmaceutical Factory, Shenzhen Saibaoer Biopharmaceutical Co., Ltd., Shandong Xinshidai Pharmaceutical Co., Ltd., Shandong Lvyin Pharmaceutical Co., Ltd. and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-thrombotic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-thrombotic Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-thrombotic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-thrombotic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-thrombotic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-thrombotic Drugs Market by Company

Yantai Dongcheng North Pharmaceutical Co., Ltd.

Tianjin Biochemical Pharmaceutical Co., Ltd.

Tianjin Hongri Pharmaceutical Co., Ltd.

Sichuan Changzheng Pharmaceutical Co., Ltd.

Shijiazhuang Heping Pharmaceutical Factory

Shenzhen Saibaoer Biopharmaceutical Co., Ltd.

Shandong Xinshidai Pharmaceutical Co., Ltd.

Shandong Lvyin Pharmaceutical Co., Ltd.

Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Henan Yonghe Pharmaceutical Co., Ltd.

Chengdu Yuandong Biopharmaceutical Co., Ltd.

Chengdu Tongde Pharmaceutical Co., Ltd.

Chengdu Baiyu Pharmaceutical Co., Ltd.

Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.

Beijing Taide Pharmaceutical Co., Ltd.

Beijing Shuanglu Pharmaceutical Co., Ltd.

Beijing Chengji Pharmaceutical Co., Ltd.

Teva

Sanofi

Sandoz

Pfizer

Johnson & Johnson

GlaxoSmithKline

Daiichi Sankyo

Bristol Myers Squibb

Boehringer Ingelheim Pharmaceuticals

Bayer

Anti-thrombotic Drugs Segment by Type

Platelet Aggregation Inhibitors

Enzymes

Heparins

Other

Anti-thrombotic Drugs Segment by Application

Clinic

Hospital

Other

Anti-thrombotic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-thrombotic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-thrombotic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-thrombotic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-thrombotic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-thrombotic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Platelet Aggregation Inhibitors Table 2. Major Company of Enzymes Table 3. Major Company of Heparins Table 4. Major Company of Other Table 5. Global Anti-thrombotic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Anti-thrombotic Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Anti-thrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Anti-thrombotic Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Anti-thrombotic Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Anti-thrombotic Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Anti-thrombotic Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Anti-thrombotic Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Anti-thrombotic Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Anti-thrombotic Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Anti-thrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Anti-thrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Anti-thrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Anti-thrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Anti-thrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Anti-thrombotic Drugs Industry Trends Table 27. Anti-thrombotic Drugs Industry Drivers Table 28. Anti-thrombotic Drugs Industry Opportunities and Challenges Table 29. Anti-thrombotic Drugs Industry Restraints Table 30. Global Anti-thrombotic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Anti-thrombotic Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Anti-thrombotic Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Anti-thrombotic Drugs Sales Share by Company (2021-2026) Table 34. Global Anti-thrombotic Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Anti-thrombotic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Anti-thrombotic Drugs Major Company Production Sites and Headquarters Table 37. Global Anti-thrombotic Drugs Company, Product Type & Application Table 38. Global Anti-thrombotic Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Anti-thrombotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Anti-thrombotic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Anti-thrombotic Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Anti-thrombotic Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Anti-thrombotic Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Anti-thrombotic Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Anti-thrombotic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Anti-thrombotic Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Anti-thrombotic Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Anti-thrombotic Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Anti-thrombotic Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Anti-thrombotic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Anti-thrombotic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Anti-thrombotic Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Anti-thrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Anti-thrombotic Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Anti-thrombotic Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Anti-thrombotic Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Anti-thrombotic Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Anti-thrombotic Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Anti-thrombotic Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Anti-thrombotic Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Anti-thrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Anti-thrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Anti-thrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Anti-thrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Anti-thrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information Table 74. Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview Table 75. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 77. Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Development Table 78. Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information Table 79. Tianjin Biochemical Pharmaceutical Co., Ltd. Business Overview Table 80. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 82. Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Development Table 83. Tianjin Hongri Pharmaceutical Co., Ltd. Company Information Table 84. Tianjin Hongri Pharmaceutical Co., Ltd. Business Overview Table 85. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 87. Tianjin Hongri Pharmaceutical Co., Ltd. Recent Development Table 88. Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information Table 89. Sichuan Changzheng Pharmaceutical Co., Ltd. Business Overview Table 90. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 92. Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Development Table 93. Shijiazhuang Heping Pharmaceutical Factory Company Information Table 94. Shijiazhuang Heping Pharmaceutical Factory Business Overview Table 95. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio Table 97. Shijiazhuang Heping Pharmaceutical Factory Recent Development Table 98. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information Table 99. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Business Overview Table 100. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 102. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Development Table 103. Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information Table 104. Shandong Xinshidai Pharmaceutical Co., Ltd. Business Overview Table 105. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 107. Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Development Table 108. Shandong Lvyin Pharmaceutical Co., Ltd. Company Information Table 109. Shandong Lvyin Pharmaceutical Co., Ltd. Business Overview Table 110. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 112. Shandong Lvyin Pharmaceutical Co., Ltd. Recent Development Table 113. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information Table 114. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Business Overview Table 115. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 117. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Development Table 118. Henan Yonghe Pharmaceutical Co., Ltd. Company Information Table 119. Henan Yonghe Pharmaceutical Co., Ltd. Business Overview Table 120. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 122. Henan Yonghe Pharmaceutical Co., Ltd. Recent Development Table 123. Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information Table 124. Chengdu Yuandong Biopharmaceutical Co., Ltd. Business Overview Table 125. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 127. Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Development Table 128. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information Table 129. Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview Table 130. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 132. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Development Table 133. Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information Table 134. Chengdu Baiyu Pharmaceutical Co., Ltd. Business Overview Table 135. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 137. Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Development Table 138. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information Table 139. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Business Overview Table 140. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 142. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Development Table 143. Beijing Taide Pharmaceutical Co., Ltd. Company Information Table 144. Beijing Taide Pharmaceutical Co., Ltd. Business Overview Table 145. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 147. Beijing Taide Pharmaceutical Co., Ltd. Recent Development Table 148. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information Table 149. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview Table 150. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 152. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development Table 153. Beijing Chengji Pharmaceutical Co., Ltd. Company Information Table 154. Beijing Chengji Pharmaceutical Co., Ltd. Business Overview Table 155. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio Table 157. Beijing Chengji Pharmaceutical Co., Ltd. Recent Development Table 158. Teva Company Information Table 159. Teva Business Overview Table 160. Teva Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Teva Anti-thrombotic Drugs Product Portfolio Table 162. Teva Recent Development Table 163. Sanofi Company Information Table 164. Sanofi Business Overview Table 165. Sanofi Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Sanofi Anti-thrombotic Drugs Product Portfolio Table 167. Sanofi Recent Development Table 168. Sandoz Company Information Table 169. Sandoz Business Overview Table 170. Sandoz Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Sandoz Anti-thrombotic Drugs Product Portfolio Table 172. Sandoz Recent Development Table 173. Pfizer Company Information Table 174. Pfizer Business Overview Table 175. Pfizer Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. Pfizer Anti-thrombotic Drugs Product Portfolio Table 177. Pfizer Recent Development Table 178. Johnson & Johnson Company Information Table 179. Johnson & Johnson Business Overview Table 180. Johnson & Johnson Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. Johnson & Johnson Anti-thrombotic Drugs Product Portfolio Table 182. Johnson & Johnson Recent Development Table 183. GlaxoSmithKline Company Information Table 184. GlaxoSmithKline Business Overview Table 185. GlaxoSmithKline Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio Table 187. GlaxoSmithKline Recent Development Table 188. Daiichi Sankyo Company Information Table 189. Daiichi Sankyo Business Overview Table 190. Daiichi Sankyo Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 191. Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio Table 192. Daiichi Sankyo Recent Development Table 193. Bristol Myers Squibb Company Information Table 194. Bristol Myers Squibb Business Overview Table 195. Bristol Myers Squibb Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 196. Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio Table 197. Bristol Myers Squibb Recent Development Table 198. Boehringer Ingelheim Pharmaceuticals Company Information Table 199. Boehringer Ingelheim Pharmaceuticals Business Overview Table 200. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 201. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio Table 202. Boehringer Ingelheim Pharmaceuticals Recent Development Table 203. Bayer Company Information Table 204. Bayer Business Overview Table 205. Bayer Anti-thrombotic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 206. Bayer Anti-thrombotic Drugs Product Portfolio Table 207. Bayer Recent Development Table 208. North America Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 209. North America Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units) Table 210. North America Anti-thrombotic Drugs Sales Market Share by Country (2021-2026) Table 211. North America Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 212. North America Anti-thrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 213. North America Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. North America Anti-thrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 215. North America Anti-thrombotic Drugs Market Share by Country (2021-2026) Table 216. North America Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. North America Anti-thrombotic Drugs Market Share Forecast by Country (2027-2032) Table 218. Europe Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 219. Europe Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units) Table 220. Europe Anti-thrombotic Drugs Sales Market Share by Country (2021-2026) Table 221. Europe Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 222. Europe Anti-thrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 223. Europe Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Europe Anti-thrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 225. Europe Anti-thrombotic Drugs Market Share by Country (2021-2026) Table 226. Europe Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Europe Anti-thrombotic Drugs Market Share Forecast by Country (2027-2032) Table 228. Asia-Pacific Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 229. Asia-Pacific Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units) Table 230. Asia-Pacific Anti-thrombotic Drugs Sales Market Share by Country (2021-2026) Table 231. Asia-Pacific Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 232. Asia-Pacific Anti-thrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 233. Asia-Pacific Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 234. Asia-Pacific Anti-thrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 235. Asia-Pacific Anti-thrombotic Drugs Market Share by Country (2021-2026) Table 236. Asia-Pacific Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 237. Asia-Pacific Anti-thrombotic Drugs Market Share Forecast by Country (2027-2032) Table 238. Latin America Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 239. Latin America Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units) Table 240. Latin America Anti-thrombotic Drugs Sales Market Share by Country (2021-2026) Table 241. Latin America Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 242. Latin America Anti-thrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 243. Latin America Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 244. Latin America Anti-thrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 245. Latin America Anti-thrombotic Drugs Market Share by Country (2021-2026) Table 246. Latin America Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 247. Latin America Anti-thrombotic Drugs Market Share Forecast by Country (2027-2032) Table 248. Middle East and Africa Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 249. Middle East and Africa Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units) Table 250. Middle East and Africa Anti-thrombotic Drugs Sales Market Share by Country (2021-2026) Table 251. Middle East and Africa Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 252. Middle East and Africa Anti-thrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 253. Middle East and Africa Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. Middle East and Africa Anti-thrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 255. Middle East and Africa Anti-thrombotic Drugs Market Share by Country (2021-2026) Table 256. Middle East and Africa Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. Middle East and Africa Anti-thrombotic Drugs Market Share Forecast by Country (2027-2032) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. Anti-thrombotic Drugs Distributors List Table 261. Anti-thrombotic Drugs Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. Anti-thrombotic Drugs Image Figure 2. Global Anti-thrombotic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-thrombotic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-thrombotic Drugs Sales (2021-2032) & (K Units) Figure 5. Platelet Aggregation Inhibitors Image Figure 6. Global Platelet Aggregation Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Enzymes Image Figure 8. Global Enzymes Sales YoY Growth (2021-2032) & (K Units) Figure 9. Heparins Image Figure 10. Global Heparins Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Anti-thrombotic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Anti-thrombotic Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Anti-thrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Anti-thrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Anti-thrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Anti-thrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Anti-thrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Anti-thrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Anti-thrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Anti-thrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Anti-thrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Anti-thrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Anti-thrombotic Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Anti-thrombotic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-thrombotic Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Anti-thrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-thrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-thrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-thrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-thrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-thrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-thrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-thrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-thrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-thrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-thrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Anti-thrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-thrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-thrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Anti-thrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-thrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-thrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Anti-thrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-thrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-thrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Anti-thrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-thrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-thrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Anti-thrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-thrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-thrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-thrombotic Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-thrombotic Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Platelet Aggregation Inhibitors
  • Enzymes
  • Heparins
  • Other
Applications
  • Clinic
  • Hospital
  • Other
Companies covered
  • Yantai Dongcheng North Pharmaceutical Co., Ltd.
  • Tianjin Biochemical Pharmaceutical Co., Ltd.
  • Tianjin Hongri Pharmaceutical Co., Ltd.
  • Sichuan Changzheng Pharmaceutical Co., Ltd.
  • Shijiazhuang Heping Pharmaceutical Factory
  • Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
  • Shandong Xinshidai Pharmaceutical Co., Ltd.
  • Shandong Lvyin Pharmaceutical Co., Ltd.
  • Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
  • Henan Yonghe Pharmaceutical Co., Ltd.
  • Chengdu Yuandong Biopharmaceutical Co., Ltd.
  • Chengdu Tongde Pharmaceutical Co., Ltd.
  • Chengdu Baiyu Pharmaceutical Co., Ltd.
  • Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
  • Beijing Taide Pharmaceutical Co., Ltd.
  • Beijing Shuanglu Pharmaceutical Co., Ltd.
  • Beijing Chengji Pharmaceutical Co., Ltd.
  • Teva
  • Sanofi
  • Sandoz
  • Pfizer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Daiichi Sankyo
  • Bristol Myers Squibb
  • Boehringer Ingelheim Pharmaceuticals
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-thrombotic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-thrombotic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-thrombotic Drugs Market by Type
  6. 1.3.1 Platelet Aggregation Inhibitors
  7. 1.3.2 Enzymes
  8. 1.3.3 Heparins
  9. 1.3.4 Other
  10. 1.4 Global Anti-thrombotic Drugs Market Size by Type
  11. 1.4.1 Global Anti-thrombotic Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Anti-thrombotic Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Anti-thrombotic Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Anti-thrombotic Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Anti-thrombotic Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Anti-thrombotic Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Anti-thrombotic Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Anti-thrombotic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-thrombotic Drugs Industry Trends
  2. 2.2 Anti-thrombotic Drugs Industry Drivers
  3. 2.3 Anti-thrombotic Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-thrombotic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-thrombotic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-thrombotic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-thrombotic Drugs Price (2021-2026)
  4. 3.4 Global Anti-thrombotic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-thrombotic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-thrombotic Drugs Company, Product Type & Application
  7. 3.7 Global Anti-thrombotic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-thrombotic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-thrombotic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-thrombotic Drugs Tier 1, Tier 2, and Tier 3
4 Anti-thrombotic Drugs Regional Status and Outlook
  1. 4.1 Global Anti-thrombotic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-thrombotic Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-thrombotic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-thrombotic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-thrombotic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-thrombotic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-thrombotic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-thrombotic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-thrombotic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-thrombotic Drugs by Application
  1. 5.1 Anti-thrombotic Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Anti-thrombotic Drugs Market Size by Application
  6. 5.2.1 Global Anti-thrombotic Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anti-thrombotic Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anti-thrombotic Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anti-thrombotic Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anti-thrombotic Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anti-thrombotic Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anti-thrombotic Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anti-thrombotic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yantai Dongcheng North Pharmaceutical Co., Ltd.
  2. 6.1.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  6. 6.1.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Tianjin Biochemical Pharmaceutical Co., Ltd.
  8. 6.2.1 Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Tianjin Biochemical Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  12. 6.2.5 Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Tianjin Hongri Pharmaceutical Co., Ltd.
  14. 6.3.1 Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Tianjin Hongri Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  18. 6.3.5 Tianjin Hongri Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Sichuan Changzheng Pharmaceutical Co., Ltd.
  20. 6.4.1 Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Sichuan Changzheng Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  24. 6.4.5 Sichuan Changzheng Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shijiazhuang Heping Pharmaceutical Factory
  26. 6.5.1 Shijiazhuang Heping Pharmaceutical Factory Company Information
  27. 6.5.2 Shijiazhuang Heping Pharmaceutical Factory Business Overview
  28. 6.5.3 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolio
  30. 6.5.5 Shijiazhuang Heping Pharmaceutical Factory Recent Developments
  31. 6.6 Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
  32. 6.6.1 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  36. 6.6.5 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shandong Xinshidai Pharmaceutical Co., Ltd.
  38. 6.7.1 Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shandong Xinshidai Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  42. 6.7.5 Shandong Xinshidai Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Shandong Lvyin Pharmaceutical Co., Ltd.
  44. 6.8.1 Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Shandong Lvyin Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  48. 6.8.5 Shandong Lvyin Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
  50. 6.9.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  54. 6.9.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Henan Yonghe Pharmaceutical Co., Ltd.
  56. 6.10.1 Henan Yonghe Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Henan Yonghe Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  60. 6.10.5 Henan Yonghe Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Chengdu Yuandong Biopharmaceutical Co., Ltd.
  62. 6.11.1 Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Chengdu Yuandong Biopharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  66. 6.11.5 Chengdu Yuandong Biopharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Chengdu Tongde Pharmaceutical Co., Ltd.
  68. 6.12.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  72. 6.12.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Chengdu Baiyu Pharmaceutical Co., Ltd.
  74. 6.13.1 Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Chengdu Baiyu Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  78. 6.13.5 Chengdu Baiyu Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
  80. 6.14.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  84. 6.14.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Beijing Taide Pharmaceutical Co., Ltd.
  86. 6.15.1 Beijing Taide Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Beijing Taide Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  90. 6.15.5 Beijing Taide Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Beijing Shuanglu Pharmaceutical Co., Ltd.
  92. 6.16.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  96. 6.16.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Beijing Chengji Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Chengji Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Chengji Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolio
  102. 6.17.5 Beijing Chengji Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Teva
  104. 6.18.1 Teva Company Information
  105. 6.18.2 Teva Business Overview
  106. 6.18.3 Teva Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Teva Anti-thrombotic Drugs Product Portfolio
  108. 6.18.5 Teva Recent Developments
  109. 6.19 Sanofi
  110. 6.19.1 Sanofi Company Information
  111. 6.19.2 Sanofi Business Overview
  112. 6.19.3 Sanofi Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Sanofi Anti-thrombotic Drugs Product Portfolio
  114. 6.19.5 Sanofi Recent Developments
  115. 6.20 Sandoz
  116. 6.20.1 Sandoz Company Information
  117. 6.20.2 Sandoz Business Overview
  118. 6.20.3 Sandoz Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Sandoz Anti-thrombotic Drugs Product Portfolio
  120. 6.20.5 Sandoz Recent Developments
  121. 6.21 Pfizer
  122. 6.21.1 Pfizer Company Information
  123. 6.21.2 Pfizer Business Overview
  124. 6.21.3 Pfizer Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Pfizer Anti-thrombotic Drugs Product Portfolio
  126. 6.21.5 Pfizer Recent Developments
  127. 6.22 Johnson & Johnson
  128. 6.22.1 Johnson & Johnson Company Information
  129. 6.22.2 Johnson & Johnson Business Overview
  130. 6.22.3 Johnson & Johnson Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Johnson & Johnson Anti-thrombotic Drugs Product Portfolio
  132. 6.22.5 Johnson & Johnson Recent Developments
  133. 6.23 GlaxoSmithKline
  134. 6.23.1 GlaxoSmithKline Company Information
  135. 6.23.2 GlaxoSmithKline Business Overview
  136. 6.23.3 GlaxoSmithKline Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 GlaxoSmithKline Anti-thrombotic Drugs Product Portfolio
  138. 6.23.5 GlaxoSmithKline Recent Developments
  139. 6.24 Daiichi Sankyo
  140. 6.24.1 Daiichi Sankyo Company Information
  141. 6.24.2 Daiichi Sankyo Business Overview
  142. 6.24.3 Daiichi Sankyo Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Daiichi Sankyo Anti-thrombotic Drugs Product Portfolio
  144. 6.24.5 Daiichi Sankyo Recent Developments
  145. 6.25 Bristol Myers Squibb
  146. 6.25.1 Bristol Myers Squibb Company Information
  147. 6.25.2 Bristol Myers Squibb Business Overview
  148. 6.25.3 Bristol Myers Squibb Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolio
  150. 6.25.5 Bristol Myers Squibb Recent Developments
  151. 6.26 Boehringer Ingelheim Pharmaceuticals
  152. 6.26.1 Boehringer Ingelheim Pharmaceuticals Company Information
  153. 6.26.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  154. 6.26.3 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolio
  156. 6.26.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
  157. 6.27 Bayer
  158. 6.27.1 Bayer Company Information
  159. 6.27.2 Bayer Business Overview
  160. 6.27.3 Bayer Anti-thrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Bayer Anti-thrombotic Drugs Product Portfolio
  162. 6.27.5 Bayer Recent Developments
7 North America by Country
  1. 7.1 North America Anti-thrombotic Drugs Sales by Country
  2. 7.1.1 North America Anti-thrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-thrombotic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-thrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-thrombotic Drugs Market Size by Country
  6. 7.2.1 North America Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-thrombotic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-thrombotic Drugs Sales by Country
  2. 8.1.1 Europe Anti-thrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-thrombotic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-thrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-thrombotic Drugs Market Size by Country
  6. 8.2.1 Europe Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-thrombotic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-thrombotic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-thrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-thrombotic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-thrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-thrombotic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-thrombotic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-thrombotic Drugs Sales by Country
  2. 10.1.1 South America Anti-thrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-thrombotic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-thrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-thrombotic Drugs Market Size by Country
  6. 10.2.1 South America Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-thrombotic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-thrombotic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-thrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-thrombotic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-thrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-thrombotic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-thrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-thrombotic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-thrombotic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-thrombotic Drugs Value Chain Analysis
  2. 12.1.1 Anti-thrombotic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-thrombotic Drugs Production Mode & Process
  7. 12.2 Anti-thrombotic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-thrombotic Drugs Distributors
  10. 12.2.3 Anti-thrombotic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst